Aristides Capital LLC Invests $209,000 in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Aristides Capital LLC bought a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) in the 4th quarter, HoldingsChannel reports. The firm bought 21,300 shares of the company’s stock, valued at approximately $209,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DNA. SBI Securities Co. Ltd. acquired a new stake in Ginkgo Bioworks during the fourth quarter worth $29,000. KBC Group NV purchased a new position in shares of Ginkgo Bioworks in the 4th quarter valued at about $31,000. KLP Kapitalforvaltning AS acquired a new position in Ginkgo Bioworks during the 4th quarter worth approximately $46,000. Bank of New York Mellon Corp grew its stake in shares of Ginkgo Bioworks by 48.2% during the fourth quarter. Bank of New York Mellon Corp now owns 23,061 shares of the company’s stock worth $226,000 after purchasing an additional 7,503 shares in the last quarter. Finally, Monaco Asset Management SAM increased its holdings in shares of Ginkgo Bioworks by 3.9% in the 4th quarter. Monaco Asset Management SAM now owns 384,664 shares of the company’s stock valued at $3,777,000 after acquiring an additional 14,539 shares during the last quarter. 78.63% of the stock is currently owned by institutional investors and hedge funds.

Ginkgo Bioworks Trading Down 2.8 %

DNA stock opened at $5.54 on Monday. Ginkgo Bioworks Holdings, Inc. has a twelve month low of $5.00 and a twelve month high of $47.60. The stock has a market cap of $321.39 million, a P/E ratio of -0.42 and a beta of 1.34. The company’s 50 day moving average is $9.71 and its two-hundred day moving average is $9.23.

Ginkgo Bioworks Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.